Doseloop Beta

Quazepam

medication Under review

A benzodiazepine medication used for the short-term treatment of insomnia.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

Human studies of quazepam are focused largely on adults with insomnia and healthy volunteers, rather than on general wellness applications. Placebo-controlled sleep laboratory and outpatient trials consistently show that quazepam at doses of 7.5โ€“15 mg improves objective and subjective sleep measures, including sleep latency, total sleep time, number of awakenings, early morning awakening, and overall sleep quality. These effects have been demonstrated over short-term periods of several nights and in longer-term studies of up to four weeks and, in some trials, nearly a month of continuous use. In healthy human volunteers, single-dose pharmacodynamic studies indicate that quazepam produces minimal impairment of psychomotor performance, memory, and daytime alertness at standard hypnotic doses, especially when compared with shorter-acting benzodiazepines such as triazolam and non-benzodiazepine hypnotics like zolpidem. Nonetheless, sleep laboratory data in patients show that daytime sleepiness can occur with sustained use, reflecting its long half-life and active metabolites. Overall, the research supports quazepam as an effective hypnotic for insomnia with a relatively favorable cognitive and performance profile at therapeutic doses, but with recognized risks of sedation, tolerance, and dependence typical of benzodiazepine-class drugs.

Reported Benefits

Reported Side Effects

Related health conditions

Research showing how this habit affects specific health conditions. Always consult healthcare professionals.

May Help With

May Worsen

Research (4 studies)

RCT

Quazepam and temazepam: effects of short- and intermediate-term use and withdrawal.

Journal of Clinical Psychopharmacology • 1985 • n=22

Roehrs T, Zorick F, Conway W, et al.

RCT

Quazepam and flurazepam: long-term use and extended withdrawal

Journal of Clinical Psychopharmacology • 1984 • n=30

Roehrs T, Zorick F, Wittig R, Conway W, Roth T

RCT

Short-term study of quazepam 15 milligrams in the treatment of insomnia.

Journal of Clinical Psychopharmacology • 1982 • n=36

Roehrs T, Zorick F, Wittig R, Conway W, Roth T

RCT

A clinical study of quazepam in hospitalized patients with insomnia

Journal of International Medical Research • 1981 • n=40

Uhthoff HK, Brunet JA, Aggerwal A, Varin R

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 4
Researched benefits 3
Side effects noted 3